Lisa Argnani

2.7k total citations
120 papers, 1.4k citations indexed

About

Lisa Argnani is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Lisa Argnani has authored 120 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pathology and Forensic Medicine, 52 papers in Oncology and 30 papers in Genetics. Recurrent topics in Lisa Argnani's work include Lymphoma Diagnosis and Treatment (84 papers), CNS Lymphoma Diagnosis and Treatment (30 papers) and Viral-associated cancers and disorders (30 papers). Lisa Argnani is often cited by papers focused on Lymphoma Diagnosis and Treatment (84 papers), CNS Lymphoma Diagnosis and Treatment (30 papers) and Viral-associated cancers and disorders (30 papers). Lisa Argnani collaborates with scholars based in Italy, United States and Ukraine. Lisa Argnani's co-authors include Pier Luigi Zinzani, Alessandro Broccoli, Cinzia Pellegrini, Vittorio Stefoni, Enrico Derenzini, Michele Baccarani, Letizia Gandolfi, Stefano Pileri, Federica Quirini and Beatrice Casadei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lisa Argnani

109 papers receiving 1.4k citations

Peers

Lisa Argnani
Felicitas Hitz Switzerland
Clíona Grant United States
Richard van der Jagt Canada
Elisabetta Todisco Italy
Jochen Heymanns Germany
B. W. Hancock United Kingdom
Allison Rosenthal United States
David Andorsky United States
H. Köppler Germany
David J. Straus United States
Felicitas Hitz Switzerland
Lisa Argnani
Citations per year, relative to Lisa Argnani Lisa Argnani (= 1×) peers Felicitas Hitz

Countries citing papers authored by Lisa Argnani

Since Specialization
Citations

This map shows the geographic impact of Lisa Argnani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Argnani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Argnani more than expected).

Fields of papers citing papers by Lisa Argnani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Argnani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Argnani. The network helps show where Lisa Argnani may publish in the future.

Co-authorship network of co-authors of Lisa Argnani

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Argnani. A scholar is included among the top collaborators of Lisa Argnani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Argnani. Lisa Argnani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gangemi, Antonio, Lisa Argnani, M. Negri, et al.. (2025). The CONVERSION Study: Open Conversion Risk in Robotic vs Laparoscopic Surgery—A 20-Year Meta-analysis. Annals of Surgery.
2.
Casadei, Beatrice, Lisa Argnani, Alessandro Broccoli, et al.. (2025). Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study. Blood Advances. 9(9). 2044–2047.
3.
4.
Stefoni, Vittorio, Alessandro Broccoli, Lisa Argnani, et al.. (2024). Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024004–e2024004. 1 indexed citations
5.
Stefoni, Vittorio, Lisa Argnani, Beatrice Casadei, et al.. (2023). Gut microbiome in DLBCL patients undergoing first‐line R‐CHOP regimen—The Oncopassport Study. Hematological Oncology. 41(S2). 283–285. 1 indexed citations
6.
Carrara, Greta, Lisa Argnani, Anna Zanetti, et al.. (2022). Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology. Scandinavian Journal of Rheumatology. 51(5). 363–367. 2 indexed citations
7.
Perrone, Anna Myriam, Gloria Ravegnini, Lisa Argnani, et al.. (2021). Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies. Cancers. 13(9). 1993–1993. 12 indexed citations
8.
Perrone, Anna Myriam, Martina Ferioli, Lisa Argnani, et al.. (2021). Quality of Life with Vulvar Carcinoma Treated with Palliative Electrochemotherapy: The ELECHTRA (ELEctroCHemoTherapy vulvaR cAncer) Study. Cancers. 13(7). 1622–1622. 12 indexed citations
9.
Casadei, Beatrice, Lisa Argnani, Alessandro Broccoli, et al.. (2020). Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients. Annals of Hematology. 100(9). 2261–2268. 6 indexed citations
10.
11.
Broccoli, Alessandro, Michelangelo Fiorentino, Vittorio Stefoni, et al.. (2019). <p><em>BRAF</em> V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia</p>. OncoTargets and Therapy. Volume 12. 4807–4812. 3 indexed citations
12.
Bonfichi, Maurizio, Simone Ferrero, Giacomo Malipiero, et al.. (2018). Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program. Hematological Oncology. 36(4). 689–692. 6 indexed citations
13.
Stefoni, Vittorio, Beatrice Casadei, Barbara Botto, et al.. (2017). The Bbv Regimen: A Phase II Study with Bendamustine Plus Brentuximab Vedotin in Hodgkin Lymphoma and CD30+ Peripheral T-Cell Lymphoma in First Salvage Setting. Blood. 130. 4087–4087. 1 indexed citations
14.
Argnani, Lisa, Alessandro Broccoli, & Pier Luigi Zinzani. (2017). Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treatment Reviews. 61. 61–69. 22 indexed citations
15.
Stefoni, Vittorio, Beatrice Casadei, Chiara Bottelli, et al.. (2016). Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results. Blood Cancer Journal. 6(5). e425–e425. 9 indexed citations
16.
Zinzani, Pier Luigi, Simonetta Viviani, Umberto Vitolo, et al.. (2013). Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. Haematologica. 98(8). 1232–1236. 50 indexed citations
17.
Derenzini, Enrico, Vittorio Stefoni, Roberto Maglie, et al.. (2013). Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. Biology of Blood and Marrow Transplantation. 19(12). 1695–1701. 7 indexed citations
18.
Toselli, Stefania, et al.. (2011). Food habits and nutritional status of adolescents in Emilia-Romagna, Italy.. PubMed. 25(4). 613–21. 13 indexed citations
19.
Zinzani, Pier Luigi, Luigi Rigacci, Vittorio Stefoni, et al.. (2011). Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients. European Journal of Nuclear Medicine and Molecular Imaging. 39(1). 4–12. 82 indexed citations
20.
Zinzani, Pier Luigi, Cinzia Pellegrini, Vittorio Stefoni, et al.. (2010). Hairy cell leukemia. Cancer. 116(20). 4788–4792. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felicitas Hitz Breakdown of academic impact, for papers by Clíona Grant Breakdown of academic impact, for papers by Richard van der Jagt Breakdown of academic impact, for papers by Elisabetta Todisco Breakdown of academic impact, for papers by Jochen Heymanns Breakdown of academic impact, for papers by B. W. Hancock Breakdown of academic impact, for papers by Allison Rosenthal Breakdown of academic impact, for papers by David Andorsky Breakdown of academic impact, for papers by H. Köppler Breakdown of academic impact, for papers by David J. Straus
Rankless by CCL
2026